Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Fischer

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
American Heart Journal|March 27, 2007
N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudyFons Windhausen, Alexander Hirsch, Gerard T Sanders, et al.
The American Journal of Cardiology|December 14, 2004
Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary interventionRobbert J de Winter, An Stroobants, Karel T Koch, et al.
Clinical Chemistry|April 11, 2009
Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin TFons Windhausen, Alexander Hirsch, Johan Fischer, et al.
The American Journal of Medicine|August 2, 2003
C-reactive protein and coronary events following percutaneous coronary angioplastyRobbert J de Winter, Karel T Koch, Jan P van Straalen, et al.
American Heart Journal|May 22, 2012
Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarctionPeter Damman, Wichert J Kuijt, Pier Woudstra, et al.
The American Journal of Cardiology|April 13, 2010
Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionJoost D E Haeck, Niels J W Verouden, Wichert J Kuijt, et al.
The American Journal of Cardiology|September 28, 2011
Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary interventionLoes P Hoebers, Peter Damman, Bimmer E Claessen, et al.
The American Journal of Cardiology|April 13, 2010
Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary interventionNiels J W Verouden, Joost D E Haeck, Wichert J Kuijt, et al.
Journal of the American College of Cardiology|December 28, 2010
Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarctionPeter Damman, Marcel A M Beijk, Wichert J Kuijt, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
American Heart Journal|March 27, 2007
N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudyFons Windhausen, Alexander Hirsch, Gerard T Sanders, et al.
The American Journal of Cardiology|December 14, 2004
Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary interventionRobbert J de Winter, An Stroobants, Karel T Koch, et al.
Clinical Chemistry|April 11, 2009
Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin TFons Windhausen, Alexander Hirsch, Johan Fischer, et al.
The American Journal of Medicine|August 2, 2003
C-reactive protein and coronary events following percutaneous coronary angioplastyRobbert J de Winter, Karel T Koch, Jan P van Straalen, et al.
American Heart Journal|May 22, 2012
Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarctionPeter Damman, Wichert J Kuijt, Pier Woudstra, et al.
The American Journal of Cardiology|April 13, 2010
Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionJoost D E Haeck, Niels J W Verouden, Wichert J Kuijt, et al.
The American Journal of Cardiology|September 28, 2011
Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary interventionLoes P Hoebers, Peter Damman, Bimmer E Claessen, et al.
The American Journal of Cardiology|April 13, 2010
Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary interventionNiels J W Verouden, Joost D E Haeck, Wichert J Kuijt, et al.
Journal of the American College of Cardiology|December 28, 2010
Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarctionPeter Damman, Marcel A M Beijk, Wichert J Kuijt, et al.
Pageof 2